Does OCTREOTIDE Cause Neoplasm malignant? 243 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 243 reports of Neoplasm malignant have been filed in association with OCTREOTIDE (Octreotide Acetate). This represents 1.0% of all adverse event reports for OCTREOTIDE.
243
Reports of Neoplasm malignant with OCTREOTIDE
1.0%
of all OCTREOTIDE reports
55
Deaths
66
Hospitalizations
How Dangerous Is Neoplasm malignant From OCTREOTIDE?
Of the 243 reports, 55 (22.6%) resulted in death, 66 (27.2%) required hospitalization, and 14 (5.8%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCTREOTIDE. However, 243 reports have been filed with the FAERS database.
What Other Side Effects Does OCTREOTIDE Cause?
Death (3,801)
Diarrhoea (3,621)
Fatigue (2,933)
Blood pressure increased (2,799)
Needle issue (2,740)
Malaise (2,737)
Pain (2,366)
Blood pressure systolic increased (2,340)
Malignant neoplasm progression (2,306)
Nausea (2,294)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which OCTREOTIDE Alternatives Have Lower Neoplasm malignant Risk?
OCTREOTIDE vs OCTREOTIDE\OCTREOTIDE
OCTREOTIDE vs ODEVIXIBAT
OCTREOTIDE vs OFATUMUMAB
OCTREOTIDE vs OFLOXACIN
OCTREOTIDE vs OLANZAPINE